Meagan Ryan, of the Der and Cox labs, was recently awarded a NIH fellowship grant (F31) for her application entitled “Defining the Role of ERK1 and ERK2 in pancreatic cancer”. The current focus of Ryan’s research is ERK1/2 signalling in pancreatic cancer and melanoma. Well done Meagan!